Celldex Therapeutics
CLDX
#4598
Rank
A$3.35 B
Marketcap
A$42.78
Share price
2.01%
Change (1 day)
3.45%
Change (1 year)

Celldex Therapeutics (CLDX) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$97 Million

According to Celldex Therapeutics's latest financial reports the company's total liabilities are A$97 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Celldex Therapeutics - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$83.33 M14.34%
2024-12-31A$72.88 M36.21%
2023-12-31A$53.5 M37.25%
2022-12-31A$38.98 M12.26%
2021-12-31A$34.72 M0.84%
2020-12-31A$34.43 M-16.59%
2019-12-31A$41.28 M-8.39%
2018-12-31A$45.06 M-55.61%
2017-12-31A$0.10 B-37.95%
2016-12-31A$0.16 B151.02%
2015-12-31A$65.17 M46.72%
2014-12-31A$44.42 M45.14%
2013-12-31A$30.6 M6.85%
2012-12-31A$28.64 M0.34%
2011-12-31A$28.54 M-16.4%
2010-12-31A$34.14 M-53.94%
2009-12-31A$74.13 M1.25%
2008-12-31A$73.22 M509.3%
2007-12-31A$12.01 M-84.03%
2006-12-31A$75.24 M253.79%
2005-12-31A$21.26 M122.55%
2004-12-31A$9.55 M109.84%
2003-12-31A$4.55 M-34.01%
2002-12-31A$6.9 M-57.12%
2001-12-31A$16.09 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
A$165.49 B 170,496.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$120.14 B 123,748.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$84.50 B 87,008.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
A$0.37 M-99.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
A$1.55 B 1,498.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$0.54 B 458.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$1.10 B 1,043.91%๐Ÿ‡บ๐Ÿ‡ธ USA